Intra-Cellular Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2007	FY 2006	FY 2005	2017 - 2019
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	2017 - 2019
Market Capitalization	0	1	1	13	0	0	Upgrade
Market Cap Growth	-95.45%	-45.68%	-91.62%	170081.98%	-90.00%	-	Upgrade
Enterprise Value	36	12	12	24	9	9	Upgrade
Last Close Price	0.01	0.05	0.10	22.00	100.00	1000.00	Upgrade
PS Ratio	-	-	-	129.15	-	-	Upgrade
PB Ratio	0.00	-0.02	-0.12	-5.52	0.02	-	Upgrade
P/FCF Ratio	-	-	-	-	0.03	-	Upgrade
P/OCF Ratio	-	-	-	-	0.02	-	Upgrade
EV/Sales Ratio	-	-	-	230.82	-	-	Upgrade
EV/FCF Ratio	-	-	-	-	36.14	-	Upgrade
Debt / Equity Ratio	-1.04	-1.04	-3.61	-4.53	30.78	-	Upgrade
Debt / FCF Ratio	-	-	-	-	42.08	-	Upgrade
Asset Turnover	-	-	-	0.01	-	-	Upgrade
Quick Ratio	-	-	-	0.00	0	-	Upgrade
Current Ratio	-	-	-	0.00	0	-	Upgrade
Return on Equity (ROE)	-	-	-	-	-1.50%	-	Upgrade
Return on Assets (ROA)	-0.20%	-0.20%	-	-14.49%	-	-	Upgrade
Return on Capital (ROIC)	-0.21%	-0.21%	-	-14.97%	-0.03%	-	Upgrade
Earnings Yield	-1656.29%	-451.64%	-138.32%	-21.57%	-30.95%	-	Upgrade
FCF Yield	-	-451.64%	-152.14%	-8.60%	3007.85%	-	Upgrade
Buyback Yield / Dilution	-1824.35%	-43.75%	-1238.72%	-3930.80%	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.